DGAP-News: Epistar Signs LED Collaboration and IP Licensing Agreement With Intermolecular

| Source: EQS Group AG
Intermolecular, Inc. 

22.04.2013 14:31

Accelerating R&D of New Materials and Manufacturing Processes for LEDs Using
Intermolecular's Combinatorial Technology Platform 

SAN JOSE, Calif., 2013-04-22 14:30 CEST (GLOBE NEWSWIRE) --
Intermolecular, Inc. (Nasdaq:IMI) announces today that Epistar, Corp.
(TWSE:2448) and Intermolecular, Inc. (Nasdaq:IMI), have signed a collaborative
development program (CDP) and royalty-bearing IP licensing agreement to
increase the efficiency and reduce cost of Epistar's light emitting diode (LED)
devices. Under this agreement, Epistar and Intermolecular engineers will work
together to leverage Intermolecular's High Productivity Combinatorial (HPC(tm))
technology platform to dramatically accelerate development and manufacturing
qualification of novel materials and processes for advanced LED products. 

'After a rigorous review of Intermolecular's capabilities through an initial
collaboration engagement, we have seen how their combinatorial approach to
materials innovation and device integration can augment Epistar's leadership in
LED technology,' said M. J. Jou, president of Epistar. 'Collaboration with our
industry partners has been critical to our world-leading R&D and manufacturing
strategy. We are confident that leveraging Intermolecular's team and technology
platform will further increase our competitive advantage.' 

The commercial LED market is highly competitive, and new technologies created
by R&D are needed to both improve light output and to reduce costs. A
multi-functional team of technologists from Epistar and Intermolecular will
work together using the HPC Platform to accelerate the pace of R&D ten times or
more compared to what can be achieved in a conventional LED lab. 

'We are very excited to partner with Epistar, a global leader in LED
manufacturing,' commented Sandeep Nijhawan, senior vice president and general
manager of Intermolecular's clean energy group. 'Entering into a strategic
engagement with a top-tier LED company like Epistar validates the applicability
and disruptive potential of the HPC technology platform for LEDs, a market that
continues to have tremendous room for growth and technology innovation.' 

Intermolecular's mission is to improve R&D efficiency in the semiconductor and
clean energy industries through collaborations that use its HPC platform, which
allows R&D experimentation to be performed at speeds up to 100 times faster
than traditional methods. 

Forward-Looking Statements

Statements made in this press release that are not statements of historical
fact are forward-looking statements. Forward-looking statements are subject to
the 'safe harbor' provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements in this press release relate, but are not
limited, to the Company's expectations for any incremental revenue related to
the technology that is being leveraged. Forward-looking statements are subject
to risks and uncertainties that could cause actual results to differ materially
from expectations, including but not limited to risks detailed from time to
time under the heading 'Risk Factors' in the Company's report on Form 10-K for
fiscal year 2011, and its subsequent reports on Form 10-Q for fiscal year 2012.
The Company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise. 

About Intermolecular, Inc.

Intermolecular(r) has pioneered a proprietary approach to accelerate research
development, innovation, and time-to-market for the semiconductor and clean
energy industries. The approach consists of its proprietary HPC(tm) platform,
coupled with its multi-disciplinary team. Through paid collaborative
development programs (CDPs) with its customers, Intermolecular develops
proprietary technology and intellectual property for its customers focused on
advanced materials, processes, integration and device architectures. Founded in
2004, Intermolecular is based in San Jose, California. 'Intermolecular' and the
Intermolecular logo are registered trademarks; and 'HPC' is a trademark of
Intermolecular, Inc.; all rights reserved. Learn more at

         CONTACT: Press Contact
         David Moreno
         MCA Public Relations
         +1.650.968.8900 x125
         Gary Hsueh, Intermolecular
         Sr. Director of Corporate Development and Investor Relations
News Source: NASDAQ OMX

22.04.2013 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

Language:     English
Company:      Intermolecular, Inc.
              United States
ISIN:         US9901240674
End of Announcement                             DGAP News-Service